Lipocine Inc (LPCN)

Lipocine Inc (LPCN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $16.9M; returns 1 day -1.4%, 1 week -7.7%, 1 year -48.4%.

Lipocine Inc. is a clinical-stage biopharmaceutical company specialized in the development of proprietary oral formulations for metabolic and endocrine disorders, leveraging its LIP'RAL drug delivery technology. The company's business model relies on a combination of royalty streams from commercialized assets and the development of a clinical pipeline for licensing or self-commercialization.

Groups LPCN belongs to

• Clinical Stage Biopharma
• Biotechnology
• Pharmaceuticals
• Metabolic Disorders
• Endocrinology
• NASH
• Mental Health Solutions
• GLP-1 Agonists
• Royalty Streams
• Healthcare
• Weight Management

LPCN financial model: income statement, cash flow and balance sheet